13F filer · CIK 1813845
BIOS Capital Management, LP
Fort Worth, TX · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$41.7M
$-11.2M vs prior
Positions
6
New / sold out
0 / 0
Added / reduced
1 / 2
Turnover
2.2%
buys $1.0M · sells $2.7M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | REIN THERAPEUTICS INC | +1,000,000 | +50.4% | +$1.0M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | LANTERN PHARMA INC | -615,038 | -71.1% | $-2.6M |
| Reduced | IN8BIO INC | -86,848 | -51.8% | $-122.5K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INCCOM | 10,049,996 | $15.4M | 36.90% |
| 2 | OPUS GENETICS INCCOM | 3,683,429 | $15.1M | 36.33% |
| 3 | COGNITION THERAPEUTICS INCCOM | 6,000,000 | $6.9M | 16.56% |
| 4 | REIN THERAPEUTICS INCCOM NEW | 2,982,375 | $3.1M | 7.44% |
| 5 | LANTERN PHARMA INCCOM | 249,397 | $1.0M | 2.50% |
| 6 | IN8BIO INCCOM NEW | 80,957 | $114.1K | 0.27% |